CHIEF-PD (CHolinesterase Inhibitor to prEvent Falls in Parkinson's Disease)
NCT04226248
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
600
Enrollment
OTHER
Sponsor class
Conditions
Parkinson Disease
Interventions
DRUG:
Rivastigmine Transdermal System
OTHER:
Placebo Transdermal System
Sponsor
University of Bristol
Collaborators
[object Object]